Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies

NCT03373968 is registered in ClinicalTrials.gov with Italfarmaco as lead sponsor.

NCT NCT03373968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03373968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies
Lead sponsor
Italfarmaco
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 24, 2017
Completion date
December 31, 2029
Enrollment
206 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy